Literature DB >> 32870576

QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights.

Ana I Lopez-Medina1, Alessandra M Campos-Staffico1, Jasmine A Luzum1.   

Abstract

Entities:  

Keywords:  COVID-19; QT prolongation; arrhythmia; azithromycin; hydroxychloroquine; ion channels; pharmacogenetics; polymorphism

Mesh：

Substances：

Year:  2020        PMID： 32870576      PMCID： PMC7845456          DOI： 10.1111/jce.14722

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN： 1045-3873


× No keyword cloud information.
  5 in total

1.  Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.

Authors:  David G Strauss; Jose Vicente; Lars Johannesen; Ksenia Blinova; Jay W Mason; Peter Weeke; Elijah R Behr; Dan M Roden; Ray Woosley; Gulum Kosova; Michael A Rosenberg; Christopher Newton-Cheh
Journal:  Circulation       Date:  2017-02-17       Impact factor: 29.690

Review 2.  Pharmacogenomics knowledge for personalized medicine.

Authors:  M Whirl-Carrillo; E M McDonagh; J M Hebert; L Gong; K Sangkuhl; C F Thorn; R B Altman; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2012-10       Impact factor: 6.875

3.  Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

Authors:  Aimée D C Paulussen; Ronaldus A H J Gilissen; Martin Armstrong; Pieter A Doevendans; Peter Verhasselt; Hubert J M Smeets; Eric Schulze-Bahr; Wilhelm Haverkamp; Günter Breithardt; Nadine Cohen; Jeroen Aerssens
Journal:  J Mol Med (Berl)       Date:  2004-02-04       Impact factor: 4.599

Review 4.  Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update.

Authors:  Maartje N Niemeijer; Marten E van den Berg; Mark Eijgelsheim; Peter R Rijnbeek; Bruno H Stricker
Journal:  Drug Saf       Date:  2015-10       Impact factor: 5.606

5.  Incidence and determinants of QT interval prolongation in COVID-19 patients treated with hydroxychloroquine and azithromycin.

Authors:  Ilir Maraj; James P Hummel; Roy Taoutel; Romy Chamoun; Virginia Workman; Cindy Li; Lydia Tran; Alexander DelVecchio; Christopher Howes; Joseph G Akar
Journal:  J Cardiovasc Electrophysiol       Date:  2020-06-20       Impact factor: 2.942
  5 in total
  1 in total

Review 1.  Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver.

Authors:  Sandeep Satsangi; Nitin Gupta; Parul Kodan
Journal:  J Clin Transl Hepatol       Date:  2021-04-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.